JNJ – Johnson & Johnson Stock Premarket Price
JNJ Premarket Chart
About Johnson & Johnson
Johnson & Johnson is a renowned multinational healthcare company. Founded in 1886, Johnson & Johnson is recognized for its diverse range of products in the pharmaceutical, medical device, and consumer health sectors. The company’s offerings include prescription drugs, medical equipment, and consumer health products such as skincare, hygiene, and baby care items. Johnson & Johnson’s commitment to healthcare innovation and consumer well-being has solidified its position as a leader in the healthcare industry. With a global presence, the company addresses medical needs and consumer demands on multiple fronts.
Latest News
- Stocks making the biggest moves midday: Frontier Group, JPMorgan, Apple, Stellantis, BlackRock and more
- Jamie Dimon says he expects S&P 500 earnings estimates to fall as companies pull guidance
- With IPOs on hold even longer, tariffs spell trouble for private tech investors
- Stocks making the biggest moves premarket: JPMorgan Chase, Newmont, Wells Fargo and more
- Wells Fargo shares climb on higher earnings, CEO calls for 'timely' trade resolution
- Unprecedented ‘shock’: Why bond yields may face even more challenges ahead
- How China's exporters are scrambling to mitigate the impact of punishing U.S. tariffs
- Stocks making the biggest moves midday: Capri, Janover, Harley-Davidson, CarMax, U.S. Steel and more
- Tariffs, trade war inflation impact to be 'pretty ugly' by summer, economists say
- How the mother of all 'short squeezes' helped drive stocks to historic gains Wednesday
- Trump’s pivot on tariffs shows that Wall Street still has a seat at his table
- Here’s the inflation breakdown for March 2025 — in one chart
- Stocks making the biggest moves premarket: Tesla, Stellantis, U.S. Steel, CarMax, Delta Air Lines and more
- Jeremy Siegel says stocks are 'not out of the woods' yet due to difficult China negotiations ahead
- Wall Street starts to cut China growth forecasts as trade tensions with U.S. escalate
- We trimmed our Wells Fargo price target after mixed earnings. But that's not the whole story
- Our 2 chip stocks are the portfolio's biggest winners in one of Wall Street’s most volatile weeks
- We're sticking with BlackRock after it delivered solid earnings in a tough market
- Morgan Stanley tops quarterly estimates as equity trading revenue surges 45%
- JPMorgan Chase is set to report first-quarter earnings – here's what the Street expects
- Trump's immigration policy is weighing on beer sales, Constellation Brands CEO says
- Modelo owner Constellation Brands outlook disappoints as tariffs weigh on forecast
- Delta CEO says Trump tariffs are hurting bookings as airline pulls 2025 forecast
- Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
- Stocks are falling but are they getting any cheaper? It's hard to say right now
- Cramer's week ahead: Banks kick off critical earnings season
- Xiaomi delivers record cars in March as winners emerge in China's EV race
- Tesla reports 336,000 vehicle deliveries in first quarter, 13% drop from a year ago
- Rivian reports sharp fall in quarterly deliveries as soft demand bites
- Huawei 2024 revenue surges to near-record high as China smartphone comeback takes hold